510(k) Report

510(k) · Cleared

Cleared

Epicage Interbody Fusion Device

K130548510(k) SpecialCleared Apr 18, 201345-day reviewClass II21 CFR 888.3080

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Alphatec Spine, Inc. · MAX Intervertebral Fusion Device With Bone Graft, Lumbar

Cleared on Apr 18, 2013 as substantially equivalent to K092901 (R Tree Innovations, 2010) after a 45-day review. Its family tree reaches back 2 generations to 1996. 1 of the 608 devices in its family, counting itself, has a Class I recall. 602 later devices descend from it.

Decided
Apr 18, 2013
Review
45 days
Class
Class II
Product code
MAX
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to P950002 (1996). 5 ancestors in all. 602 later devices descend from it, 3 citing it directly. 1 of the 608 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2009: 1 other ancestor1999: 1 other ancestor1996: 1 other ancestor2016: 21 descendants cleared2013: 1 descendant cleared2014: 4 descendants cleared2015: 8 descendants cleared2019: 43 descendants cleared2017: 28 descendants cleared2026: 59 descendants cleared2018: 31 descendants cleared2020: 64 descendants cleared2021: 51 descendants cleared, 1 with a Class I recall12022: 61 descendants cleared2025: 72 descendants cleared2024: 83 descendants cleared2023: 76 descendants clearedP950002 · Bak Interbody Fusion System · Zimmer Spine, Inc. · 1996K092901 · Epicage Interbody Fusion Device · R Tree Innovations · 20101995200020052010201520202025
Other ancestors, by generationDescendants, by generation 2 generations back: 3 other ancestors 1 generation forward: 3 descendants2 generations forward: 9 descendants3 generations forward: 28 descendants4 generations forward: 83 descendants5 generations forward: 154 descendants, 1 with a Class I recall16 generations forward: 150 descendants7 generations forward: 95 descendants8 generations forward: 49 descendants9 generations forward: 23 descendants10 generations forward: 6 descendants11 generations forward: 2 descendants K092901 · Epicage Interbody Fusion Device · R Tree Innovations · 2010P950002 · Bak Interbody Fusion System · Zimmer Spine, Inc. · 19960+5+10
  1. Root · 2 generations backP950002 Bak Interbody Fusion SystemZimmer Spine, Inc. · 1996
  2. 1 generation backK092901 Epicage Interbody Fusion DeviceR Tree Innovations · 2010
  3. This deviceK130548 Epicage Interbody Fusion DeviceAlphatec Spine, Inc. · 2013
  4. Descendant · cites it directly · 596 of its ownK132601 Coroent Sterile Implants SystemNu Vasive, Incorporated · 2013
  5. Descendant · 2 generations on · 590 of its ownK140319 Coroent TI-C SystemNuvasive, Inc. · 2014
  6. Descendant · 2 generations on · 588 of its ownK141665 NuVasive CoRoent SystemNuvasive, Inc. · 2015
  7. Descendant · 2 generations on · 483 of its ownK140659 Coroent Thoracolumbar ImplantsNu Vasive, Incorporated · 2014
  8. Descendant · 2 generations on · 480 of its ownK141896 Coroent SystemNu Vasive, Incorporated · 2014

Showing 5 of 602 descendants. See all descendants

Descendants cleared per year

2013: 12014: 42015: 82016: 212017: 282018: 312019: 432020: 642021: 512022: 612023: 762024: 832025: 722026: 59
2013high 83 (2024) · low 1 (2013)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 602 · See all
  • K132601Coroent Sterile Implants SystemNu Vasive, Incorporated · 2013 · cites it directly596descendants
  • K140319Coroent TI-C SystemNuvasive, Inc. · 2014 · 2 generations on590descendants
  • K141665NuVasive CoRoent SystemNuvasive, Inc. · 2015 · 2 generations on588descendants
  • K140659Coroent Thoracolumbar ImplantsNu Vasive, Incorporated · 2014 · 2 generations on483descendants
  • K141896Coroent SystemNu Vasive, Incorporated · 2014 · 2 generations on480descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2P950002Bak Interbody Fusion SystemZimmer Spine, Inc.1996—
−1K092901Epicage Interbody Fusion DeviceR Tree Innovations2010—
0 (this device)K130548Epicage Interbody Fusion DeviceAlphatec Spine, Inc.2013—
+1K132601Coroent Sterile Implants SystemNu Vasive, Incorporated2013—
+2K140319Coroent TI-C SystemNuvasive, Inc.2014—
+2K141665NuVasive CoRoent SystemNuvasive, Inc.2015—
+2K140659Coroent Thoracolumbar ImplantsNu Vasive, Incorporated2014—
+2K141896Coroent SystemNu Vasive, Incorporated2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
199910
200910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
201440
201580
2016210
2017280
2018310
2019430
2020640
2021511
2022610
2023760
2024830
2025720
2026590
FIG. 1 — Lineage of K130548, 1996–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MAX device

  1. #1 K203714 NuVasive Thoracolumbar Interbody Systems…score 102.5 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K092901Epicage Interbody Fusion Device
Summary page 2
…0548 2 of 2 Substantial Equivalence Claimed: The subject Epicage Interbody Fusion System is substantially equivalent to the predicate Epicage Interbody Fusion System (K092901) with the same intended use and technological characteristics. The subject system is manufactured from the same materials and man…
R Tree Innovations2010—

Also cleared against K092901: 2 other devices →

What descends from it? (602)

See all 602

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K132601Coroent Sterile Implants SystemNu Vasive, Incorporated2013596
K153123Genesys Spine Apache Interbody Fusion SystemGenesys Spine201612
K153356Spine Innovation Interbody SystemSpine Innovation, LLC20161

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K211616ExcelsiusHubGlobus Medical, Inc. · 2021 · 5 generations on · ◆ in the 2021 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 17 years and passes through 3 companies; a new generation was cleared every 13.6 years on median.
  • 2 of the 5 ancestors have a recall of any class.
  • Of its descendants, K132601 (Nu Vasive, Incorporated, 2013) has gone furthest, with 596 descendants of its own.
  • 2 other devices also cite its predicate K092901.

How does its category compare?

All MAX devices

MAX Intervertebral Fusion Device With Bone Graft, Lumbar: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · MAX

29in 2025

2007: 72008: 352009: 312010: 292011: 492012: 482013: 582014: 582015: 532016: 642017: 762018: 642019: 602020: 562021: 532022: 412023: 302024: 382025: 292026 (partial year): 18
2007high 76 (2017) · low 7 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MAX

85in 2025

2007: 86 days median2008: 88 days median2009: 102 days median2010: 137 days median2011: 98 days median2012: 69 days median2013: 102 days median2014: 115 days median2015: 113 days median2016: 124 days median2017: 116 days median2018: 114 days median2019: 131 days median2020: 106 days median2021: 109 days median2022: 95 days median2023: 87 days median2024: 91 days median2025: 85 days median2026 (partial year): 95 days median
2007high 137 (2010) · low 69 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MAX

5in 2025

2008: 22009: 92011: 32012: 11, 1 Class I2014: 32015: 12016: 62017: 12018: 42019: 12022: 12024: 12025: 5
2007high 11 (2012) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · MAX

811in 2025

2007: 122008: 192009: 902010: 1542011: 2012012: 3272013: 3802014: 3662015: 5242016: 6472017: 5962018: 6162019: 6992020: 6402021: 6222022: 6182023: 5762024: 7292025: 811
2007high 811 (2025) · low 12 (2007)2025

MAUDE reports naming product code MAX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007786012
20083588219
200931102990
2010291370154
201149983201
2012486911 (1)327
2013581020380
2014581153366
2015531131524
2016641246647
2017761161596
2018641144616
2019601311699
2020561060640
2021531090622
202241951618
202330870576
202438911729
202529855811
202618950—

What is it indicated for?

The Epicage Interbody Fusion Device is intended for interbody fusion procedures and is indicated for use in skeletally mature patients with Degenerative Disc Disease (DDD) at one or two contiguous levels from L2-SI. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These DDD patients may also have up to Grade I spondylolisthesis or retrolisthesis at the involved level(s). It is…

Read the full statement (125 words)

The Epicage Interbody Fusion Device is intended for interbody fusion procedures and is indicated for use in skeletally mature patients with Degenerative Disc Disease (DDD) at one or two contiguous levels from L2-SI. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These DDD patients may also have up to Grade I spondylolisthesis or retrolisthesis at the involved level(s). It is indicated to be used with autograft bone. Patients should have received six months of non-operative treatment prior to treatment with the devices. The device is intended to be used with supplemental posterior fixation approved for use in the lumbar spine such as Aiphatec Spine's Zodiac Polyaxial Spinal Fixation System and/or Illico Posterior Fixation System.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K130548: Epicage Interbody Fusion Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K130548

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026